| ADDEX THERAP.ADR NEW/120 |
| USA |
| Gesundheit |
| US00654J2069 / A3EXC6 |
| APE1 (Frankfurt) / ADXN (NASDAQ) |
| FRA:APE1, ETR:APE1, APE1:GR, NASDAQ:ADXN |
| - |
| http://www.addextherapeut.. |
|
Addex Therapeutics Ltd. is a leading biotechnology company focused on developing innovative therapies for neurological disorders with high unmet medical needs. The company specializes in allosteric modulation technology, paving the way for novel appr..
>Volltext.. |
| 6.93 Mio. EUR |
| 4.59 Mio. EUR |
| 0.16 Mio. EUR |
| -2.51 Mio. EUR |
| -6.23 Mio. EUR |
| -7.29 EUR |
| 0.04 Mio. EUR |
| 2.38 Mio. EUR |
| -1.73 Mio. EUR |
| 1.86 |
| -72.15% |
| -225.96% |
| - |
| - |
| - |
| - |
| ADDEX ADR, ADDEX |
| 01.04.26 |
|
||||
|